We're helping you uncover what's already on sale at great low pricesAmazon's Black Friday deals are already heating upBy ...

NVIDIA Corp (NASDAQ:NVDA) is one of the best stocks to invest in, according to billionaire D.E. Shaw. On October 30, Goldman ...

Ucupaint 2.4.0 introduces a dedicated alpha channel, decal constraint option and major UI and performance updates for Blender ...

GLTF export gains options for vertex colours, workbench materials ... At the same time, teams can use the beta phase of Blender 5.0 to begin parallel testing. Doing so will identify add-on ...

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

This strengthens Google’s position against rivals such as Microsoft and AWS as enterprises seek faster, more reliable ways to ...

To topple access barriers to Vertex Pharmaceuticals’ potentially lifesaving, yet often out-of-reach cystic fibrosis therapy Trikafta, a buyers club has resurfaced with a plan to introduce a discounted ...

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Updated data from RUBY-3 ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

News headlines Vertex Pharmaceuticals (VRTX) is gaining investor interest due to strong earnings growth expectations, with a projected 24.4% increase for the current quarter. However, recent mixed ...

After pioneering haptic gloves for virtual reality, Tokyo-based startup Diver-X is taking aim at one of the most familiar computer tools: the ...